bladder cancer
Informed Genomics, NHS to Study Use of Urine-Based Bladder Cancer Test
Studies planned for this year will be used to evaluate the accuracy of Informed Genomics' Galeas Bladder test and further studies are planned for early 2025.
J&J's Balversa Approved in Europe for FGFR3-Mutant Bladder Cancer
The approval was based on results from the Phase III THOR study, which compared Balversa to chemotherapy.
The firm is encouraged by the MAT2A inhibitor's commercial prospects after seeing its efficacy as a monotherapy in some MTAP-null bladder and lung cancer patients.
Owkin Expands Into Western Europe With Nine Precision Medicine Partnerships
The firm will employ its machine learning-enabled diagnostic and drug discovery tools in nine centers across Germany, Austria, and Switzerland.
CHMP Recommends Janssen's Balversa in FGFR3-Altered Bladder Cancer
The committee based its decision on clinical trial results showing improved overall and progression-free survival for patients on Balversa compared to chemotherapy.
Apr 5, 2024
Mar 14, 2024
Aug 23, 2023